Breaking News
February 21, 2019 - Mayo clinic researchers discuss local case studies of leprosy
February 21, 2019 - Scientists demonstrate key role of salt in allergic immune reactions
February 21, 2019 - Experts propose revising the criteria for diagnosis of Parkinson’s disease
February 21, 2019 - The med student and the machine
February 21, 2019 - Hey, Hey! Ho, Ho! Is Striking For School Nurses The Way To Go?
February 21, 2019 - Latest research encourages children to move out and learn through physical activity
February 21, 2019 - Proper oral hygiene and regular visits to dentist can promote heart health
February 21, 2019 - New, versatile technique for remote control of transplanted cells in Parkinson’s
February 21, 2019 - Why melanoma tumors in the brain may be worse?
February 21, 2019 - New project aims to improve lung disease care in Appalachia
February 21, 2019 - Drug increases melanin production in some people with albinism
February 21, 2019 - Over 1 in 3 adults miss the mark on protein, finds study
February 21, 2019 - CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
February 21, 2019 - A correlation between obesity and income has only developed in the past 30 years
February 21, 2019 - Baby, then work: An effort to help resident-parents in emergency medicine
February 21, 2019 - Heavy cigarette smoking could damage vision, say researchers
February 21, 2019 - Some drug combinations may be more effective than others for schizophrenic patients
February 21, 2019 - Combination of common antibiotics can eliminate multi-drug resistant E. coli
February 21, 2019 - New computational tool searches for factors that cause specific diseases
February 21, 2019 - New method to assess effectiveness of psychotherapies for social anxiety disorder
February 21, 2019 - New technology measures hormones that influence reproductive health efficiently
February 21, 2019 - Bat influenza viruses could potentially attack the cells of humans and livestock
February 21, 2019 - Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing
February 21, 2019 - Johns Hopkins scientists find new compound that may prevent reperfusion injury
February 21, 2019 - Researchers develop new way to deliver treatment for cartilage regeneration
February 21, 2019 - Study sheds new light on left ventricular dysfunction in ischemic heart disease
February 21, 2019 - New technique could expedite cancer diagnosis, lead to better patient outcomes
February 21, 2019 - New map of infant brain may aid early diagnosis of autism
February 21, 2019 - Human consciousness depends on the brain’s ability to maintain dynamics of neural activity
February 21, 2019 - Harmony Biosciences Announces File Acceptance Of Its New Drug Application For Pitolisant
February 21, 2019 - Medications could fill treatment gap for adolescents with obesity
February 21, 2019 - New antibiotics are desperately needed: Machine learning could help | News Center
February 21, 2019 - Researchers develop new computer game for dementia carers
February 21, 2019 - University of Dundee partners with Takeda to develop new treatments for tau pathology
February 21, 2019 - Influenza vaccine may be less effective in elderly patients, finds study
February 21, 2019 - Researchers explain why T cells lose their protective ability in inflamed tissues
February 21, 2019 - New optimization method rapidly analyzes nanomedicines for cancer treatment
February 21, 2019 - Viruses in the intestinal tracts can lead to islet autoimmunity and Type 1 diabetes
February 21, 2019 - Link between dietary fatty acid intake and hypertension found to be influenced by diabetes status
February 21, 2019 - FDA Approves Esperoct (turoctocog alfa pegol, N8-GP) for Hemophilia A
February 21, 2019 - ‘Boy erased’—why conversion therapies and ex-gay ministries should be outlawed
February 21, 2019 - Titia de Lange to give annual McCormick Lecture on March 8 | News Center
February 21, 2019 - Study reveals how helper T cells support memory cells to function optimally
February 21, 2019 - Autistic children with co-occurring ADHD have greater adaptive behavior impairments
February 21, 2019 - Elevated levels of key cellular process implicated in intestinal inflammation and IBD
February 20, 2019 - Over Half of Hip Replacements Expected to Last 25 Years
February 20, 2019 - Microscopic eye movements affect how we see contrast
February 20, 2019 - Computer vs. patient: Fighting for residents’ attention | News Center
February 20, 2019 - New “Smart Drug” Shows Promise for Metastatic Triple-Negative Breast Cancer
February 20, 2019 - Researchers develop large-scale window material for high-efficiency PM2.5 capture
February 20, 2019 - Widespread confusion among consumers on food date labels lead to unnecessary discards
February 20, 2019 - Researchers unlock plant’s secret of producing specialized metabolites
February 20, 2019 - Newly released national framework identifies obstacles to improving EMS systems
February 20, 2019 - Exercise can shift human body clock depending on time when people work out
February 20, 2019 - Female adolescent blood donors more likely to have iron deficiency and related anemia
February 20, 2019 - Rubicon level linked to inhibition of autophagic process
February 20, 2019 - Researchers find potential therapeutic strategy to treat Alzheimer’s
February 20, 2019 - New forms of older anti-cancer agent appear to enhance immune response to fight melanoma
February 20, 2019 - Health Tip: Eat Less Saturated Fat
February 20, 2019 - Sleeping in contact lenses puts you at risk of dangerous infection
February 20, 2019 - “We should study that!”: How a nurse-scientist found her passion
February 20, 2019 - Cervical microbiome may influence HPV infection more than previously thought
February 20, 2019 - Sausage mislabeling in Canada is down, new study finds
February 20, 2019 - Study shows blood pressure benefits of morning exercise for older overweight/obese adults
February 20, 2019 - New screening method could catch organ rejection much earlier without a biopsy needle
February 20, 2019 - Study may have important implications for refining parenting during child’s adolescence
February 20, 2019 - Study sheds new light on how antibiotic resistance genes are transferred between bacteria
February 20, 2019 - Chronic Wasting Disease may soon spread to humans, warns CDC
February 20, 2019 - Scientists identify new genetic causes linked to abnormal pregnancies and miscarriages
February 20, 2019 - Using LyoSpeed technology to avoid residual solvent when drying HPLC fractions
February 20, 2019 - New AI can identify, predict development of different combinations of cancer symptoms
February 20, 2019 - Scientists join forces to identify a new approach to fight African sleeping sickness
February 20, 2019 - New screening tool more likely to identify sexual and labor exploitation of youth
February 20, 2019 - Newly licensed nurses work for long hours, also have a second paid job
February 20, 2019 - Physicists identify simple mechanism used by deadly bacteria to fend off antibiotics
February 20, 2019 - FDA Grants Priority Review to Genentech’s Personalized Medicine Entrectinib
February 20, 2019 - Exposure to chemicals before and after birth is associated with a decrease in lung function
February 20, 2019 - Neuroscientists reveal that simple brain region can guide complex feats of mental activity
February 20, 2019 - Study finds new link between food allergies and multiple sclerosis
February 20, 2019 - First gene therapy operation for macular degeneration is a success
Compound scores key win in battle against antibiotic resistance

Compound scores key win in battle against antibiotic resistance

image_pdfDownload PDFimage_print
Credit: CC0 Public Domain

Researchers at Oregon State University have made a key advance in the fight against drug resistance, crafting a compound that genetically neutralizes a widespread bacterial pathogen’s ability to thwart antibiotics.

The findings are important because antibiotic resistance is a growing global threat, with the percentage of isolates with multidrug resistance on the rise for many bacteria.

“Discovery of novel antibiotics has waned, effective modifications have become less frequent, inhibitors of resistance are limited, and economic factors in the pharmaceutical industry have dried up the development pipeline,” said Bruce Geller, professor of microbiology in the OSU College of Science. “A new antibiotic scaffold effective against Gram-negative pathogens has not been approved in more than 30 years.”

Every year, 2 million people in the United States are severely infected with drug-resistant bacteria, and between the U.S. and Europe, nearly 50,000 people die annually from those types of infections. Using a traditional strategy of trying to find new antibiotics, chemically altering old ones, or combining antibiotics with resistance inhibitors, researchers have fallen behind in the race to stay ahead of drug resistance.

But Geller and collaborators are developing a new kind of antibacterial compound known as a PPMO to fight antibiotic resistance.

In their most recent study, published in the Journal of Antimicrobial Chemotherapy, PPMOs were designed and tested against Klebsiella pneumonia, an opportunistic pathogen that is difficult to kill and resistant to many antibiotics.

“Klebsiella pneumoniae is a ubiquitous bacterium that lives in a lot of different environments,” Geller said. “It’s in soil, it’s in water, it’s really hardy. It can also colonize in people’s nose and throat without causing any pathology.

“But every once in a while, something bad happens and strains just get into an area of the body where they’re not supposed to be,” Geller said. “They can get into the lungs and cause pneumonia, especially if the patient has some other underlying condition that knocks down the immune system – transplant patients whose immune system is suppressed with drugs, for example, or people with diabetes or alcoholism. It’s also a common cause of urinary tract infections, and if the bacteria get into the blood, they can kill within hours.”

In the study, PPMOs eliminated slimy secretions known as biofilms that Klebsiella makes to protect itself against antibiotics. The PPMOs were also effective in treating K. pneumoniae-infected mice – the first time a gene-specific therapeutic has been shown to be effective against K. pneumoniae in vivo, i.e., in a living organism.

“It worked in a mouse model of pneumonia using a strain of Klebsiella that is resistant to all antibiotics except one, which is toxic and not often used,” Geller said.

PPMO is short for peptide-conjugated phosphorodiamidate morpholino oligomer, which is a synthetic, nucleic acid-like molecule designed to silence bacterial gene expression; it inhibits growth by binding to specific RNA.

“PPMOs are a platform technology, which means they can be quickly designed or modified to kill just about any bacterium,” Geller said. “Because they are not naturally found in nature, bacteria have not developed resistance to them. Bacteria that are resistant to standard antibiotics are completely susceptible to PPMOs. They have the potential to be a very effective therapeutic. Molecular medicine is the way of the future.”


Explore further:
New antimicrobial strategy silences NDM-1 resistance gene in pathogens

More information:
Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae, Journal Of Antimicrobial Chemotherapy (2018). DOI: 10.1093/jac/dky058 , https://academic.oup.com/jac/advance-article-abstract/doi/10.1093/jac/dky058/4915983

Journal reference:
Journal of Antimicrobial Chemotherapy

Provided by:
Oregon State University

About author

Related Articles